调节TRPV1和TRPA1通道:使用中国草药治疗喘的可行策略
Xiang Yao1,2, Xuejian Zhang1, Tao Cui3
1Sichuan Sanlian New Material Co., Ltd., Chengdu, China.
Frontiers in pharmacology
|July 18, 2025
概括
中国草药可能通过向TRPV1和TRPA1通道来减少肺炎,提供新的喘治疗方法. 本综述探讨了它们在持续性喘缓解方面的潜力.
科学领域:
- 肺病学和药理学 肺病学和药理学
- 综合医学是一个整体的医学.
- 分子生物学分子生物学
背景情况:
- 喘是一个具有重大社会影响的全球健康问题.
- 目前的喘药物可以降低死亡率,但不能实现持久的缓解.
- 暂时受体潜在通道TRPV1和TRPA1是肺部的关键目标.
研究的目的:
- 系统地审查TRPV1/TRPA1通道在喘中的作用.
- 分析中国草药 (CHM) 如何调节喘治疗中的这些通道.
- 探索CHM作为喘药物发现的可行选择.
主要方法:
- 对134篇文章进行了系统的文献审查.
- 分析喘病原和当前治疗策略.
- 专注于CHM对TRPV1/TRPA1的作用和调制.
主要成果:
- 通过调节TRPV1/TRPA1通道,CHM在喘中表现出有益的影响.
- 有证据支持CHM缓解肺炎的能力.
- TRPV1/TRPA1通道对于喘中CHM的治疗机制至关重要.
结论:
- 通过向TRPV1/TRPA1.1,CHM提供了对喘有前途的治疗策略.
- 通过CHM调节这些通道可以导致肺炎的减少.
- 这一审查为开发有效的基于CHM的喘治疗奠定了基础.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
483
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
483
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
469
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469
Asthma: Pathogenesis and Management
599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
Antiasthma Drugs: Methylxanthines
409
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
409
Drugs Used in Lower Respiratory Disorders: Overview
595
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
595
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K


